ANTIHEMOPHILIC FACTOR (RECOMBINANT), PORCINE SEQUENCE

ANTIHEMOPHILIC FACTOR (RECOMBINANT), PORCINE SEQUENCE was reported 154 times

ANTIHEMOPHILIC FACTOR (RECOMBINANT), PORCINE SEQUENCE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMPERFORATE OESOPHAGUS 1 0.2000
1 COAGULATION FACTOR VIII LEVEL ABNORMAL 2 0.0833
2 INHIBITING ANTIBODIES 5 0.0714
3 ANTI FACTOR VIII ANTIBODY POSITIVE 37 0.0655
4 URETHRAL ABSCESS 1 0.0476
5 FACTOR VIII ACTIVITY DECREASED 1 0.0435
6 LIP HAEMATOMA 1 0.0303
7 ANTI FACTOR VIII ANTIBODY INCREASED 3 0.0242
8 ANTI FACTOR VIII ANTIBODY TEST 1 0.0222
9 INHIBITING ANTIBODIES POSITIVE 1 0.0175
10 MIXED DEMENTIA 1 0.0156
11 COAGULATION FACTOR VIII LEVEL DECREASED 2 0.0122
12 FACTOR VIII INHIBITION 8 0.0076
13 COAGULATION FACTOR VIII LEVEL INCREASED 1 0.0068
14 VESSEL PUNCTURE SITE HAEMATOMA 1 0.0051
15 HAEMOPHILIA 1 0.0047
16 DRUG CLEARANCE INCREASED 1 0.0045
17 PROTEUS TEST POSITIVE 1 0.0045
18 ORAL CONTUSION 1 0.0043
19 CHEST WALL HAEMATOMA 1 0.0039
20 BRONCHIAL HAEMORRHAGE 1 0.0032
21 POST PROCEDURAL CONTUSION 1 0.0030
22 BRONCHIAL WALL THICKENING 2 0.0028
23 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 1 0.0026
24 THERAPEUTIC PRODUCT CROSS-REACTIVITY 2 0.0022
25 RESPIRATORY TRACT INFLAMMATION 1 0.0021
26 THERAPY RESPONDER 1 0.0020
27 POSTOPERATIVE ILEUS 1 0.0018
28 BILIARY DILATATION 2 0.0014
29 THERAPEUTIC RESPONSE INCREASED 1 0.0011
30 MUSCLE HAEMORRHAGE 4 0.0010
31 INTRA-ABDOMINAL HAEMORRHAGE 2 0.0008
32 HAEMATOMA MUSCLE 1 0.0008
33 PHARYNGEAL HAEMORRHAGE 1 0.0008
34 OESOPHAGEAL HAEMORRHAGE 1 0.0008
35 NONINFECTIVE GINGIVITIS 1 0.0007
36 PULMONARY SEPSIS 1 0.0007
37 MENINGITIS ASEPTIC 3 0.0007
38 PNEUMONIA PSEUDOMONAL 1 0.0007
39 ANTIBODY TEST POSITIVE 1 0.0006
40 PSEUDOMONAL SEPSIS 1 0.0006
41 PNEUMONIA KLEBSIELLA 1 0.0005
42 HYPERCOAGULATION 1 0.0005
43 RETROPERITONEAL HAEMATOMA 1 0.0005
44 BLOOD LOSS ANAEMIA 1 0.0004
45 NECROSIS 2 0.0004
46 HAEMOTHORAX 1 0.0003
47 WOUND COMPLICATION 1 0.0003
48 PRIAPISM 1 0.0003
49 FIBRIN D DIMER INCREASED 1 0.0003
50 CHEMOTHERAPY 1 0.0003
51 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
52 CARDIOPULMONARY FAILURE 1 0.0003
53 EMBOLISM 2 0.0002
54 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
55 ATELECTASIS 2 0.0002
56 THROMBOTIC MICROANGIOPATHY 2 0.0002
57 STAPHYLOCOCCAL SEPSIS 1 0.0002
58 PETIT MAL EPILEPSY 1 0.0002
59 HAEMORRHAGE 20 0.0002
60 NONSPECIFIC REACTION 1 0.0002
61 INTESTINAL ISCHAEMIA 1 0.0002
62 ANGIOPATHY 1 0.0002
63 COVID-19 PNEUMONIA 2 0.0002
64 PLEURISY 1 0.0002
65 HIATUS HERNIA 2 0.0002
66 HAEMATOMA 4 0.0002
67 COLITIS ISCHAEMIC 1 0.0001
68 GINGIVAL BLEEDING 2 0.0001
69 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
70 HAEMARTHROSIS 1 0.0001
71 UROSEPSIS 1 0.0001
72 PRODUCT DISTRIBUTION ISSUE 1 0.0001
73 EYELID PTOSIS 1 0.0001
74 SUBARACHNOID HAEMORRHAGE 1 0.0001
75 EPILEPSY 3 0.0001
76 POOR VENOUS ACCESS 1 0.0001
77 DRUG EFFECT DECREASED 5 0.0001
78 DEEP VEIN THROMBOSIS 5 0.0001
79 ORAL DISCOMFORT 1 0.0001
80 MASS 1 0.0001
81 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
82 SUBDURAL HAEMATOMA 1 0.0001
83 CARDIOGENIC SHOCK 1 0.0001
84 SKIN HAEMORRHAGE 1 0.0001
85 THERAPEUTIC RESPONSE DECREASED 4 0.0001
86 COGNITIVE DISORDER 3 0.0001
87 PULMONARY EMBOLISM 6 0.0001
88 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
89 DELIRIUM 2 0.0001
90 OSTEOMYELITIS 1 0.0001
91 ACUTE RESPIRATORY FAILURE 1 0.0001
92 KIDNEY INFECTION 1 0.0001
93 EATING DISORDER 1 0.0000
94 THERAPY NON-RESPONDER 2 0.0000
95 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
96 RESPIRATORY TRACT INFECTION 1 0.0000
97 OXYGEN SATURATION DECREASED 2 0.0000
98 RESPIRATORY DISORDER 1 0.0000
99 CORONARY ARTERY DISEASE 1 0.0000
100 PLEURAL EFFUSION 2 0.0000
101 HAEMATURIA 1 0.0000
102 DRUG EFFECT INCOMPLETE 1 0.0000
103 SEPSIS 3 0.0000
104 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
105 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
106 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
107 ATRIAL FIBRILLATION 2 0.0000
108 LEUKOPENIA 1 0.0000
109 CELLULITIS 1 0.0000
110 DRUG INEFFECTIVE 26 0.0000
111 SPEECH DISORDER 1 0.0000
112 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
113 COVID-19 3 0.0000
114 NO ADVERSE EVENT 3 0.0000
115 DISCOMFORT 1 0.0000
116 OFF LABEL USE 14 0.0000
117 RENAL FAILURE 2 0.0000
118 NEUTROPENIA 2 0.0000
119 UNDERDOSE 1 0.0000
120 DYSGEUSIA 1 0.0000
121 UNEVALUABLE EVENT 1 0.0000
122 CONDITION AGGRAVATED 4 0.0000
123 PNEUMONIA 4 0.0000
124 TREATMENT FAILURE 1 0.0000
125 RENAL IMPAIRMENT 1 0.0000
126 CEREBROVASCULAR ACCIDENT 2 0.0000
127 CONTUSION 1 0.0000
128 DEATH 8 0.0000
129 THROMBOCYTOPENIA 1 0.0000
130 SEIZURE 1 0.0000
131 DECREASED APPETITE 2 0.0000
132 ABDOMINAL PAIN 2 0.0000
133 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
134 DEHYDRATION 1 0.0000
135 INFECTION 1 0.0000
136 HYPOAESTHESIA 1 0.0000
137 HOSPITALISATION 1 0.0000
138 CONFUSIONAL STATE 1 0.0000
139 TREMOR 1 0.0000
140 FALL 2 0.0000
141 URINARY TRACT INFECTION 1 0.0000
142 MYOCARDIAL INFARCTION 1 0.0000
143 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
144 PRODUCT USE ISSUE 1 0.0000
145 NAUSEA 2 0.0000
146 DYSPNOEA 1 0.0000